BIA
MDT icon

Benchmark Investment Advisors’s Medtronic MDT Stock Holding History

Benchmark Investment Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,548
Closed -$205K – 91
2023
Q1 		$205K Sell
2,548
-388
-13% -$31.6K 0.21% 87
2022
Q4 		$228K Sell
2,936
-933
-24% -$75.6K 0.24% 88
2022
Q3 		$312K Sell
3,869
-3,428
-47% -$308K 0.34% 73
2022
Q2 		$655K Sell
7,297
-3,101
-30% -$314K 0.68% 49
2022
Q1 		$1.15M Buy
10,398
+781
+8% +$82.5K 0.87% 33
2021
Q4 		$995K Buy
+9,617
New +$1.11M 0.82% 41

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Benchmark Investment Advisors's MDT Position: Q2 2023 in Review

Benchmark Investment Advisors sold out of Medtronic (MDT) in Q2 2023, closing a stake of 2,548 shares — an estimated $205K sold.

Benchmark Investment Advisors first reported a position in MDT in Q4 2021 and held it in 6 quarters. The position peaked at $1.15M in Q1 2022. 2,056 funds tracked by Wall St. Rank hold MDT as of Q2 2023.

  • Benchmark Investment Advisors reported no remaining Medtronic position as of Q2 2023 after selling out during the quarter.
  • Benchmark Investment Advisors sold 2,548 Medtronic shares in Q2 2023, an estimated $205K.
  • Benchmark Investment Advisors first reported a position in Medtronic in Q4 2021 and held it in 6 quarters.
  • Benchmark Investment Advisors's Medtronic position peaked at $1.15M in Q1 2022.
  • 2,056 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.

Based on Benchmark Investment Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.